Receptors for human IgG have been demonstrated on human leucocytes including monocytes Fudenberg, 1968, Abramson et al., 1970a) , polymorphonuclear neutrophils (Messner and Jelinek, 1970) and a subpopulation of lymphocytes (Brain and Marston, 1973; Fr0land et al., 1974a) . That the receptor recognizes the Fc fragment of IgG has been demonstrated by the inhibition of IgG binding to cells by isolated Fc but not Fab or F(ab')2 fragments (Abramson et al., 1970b; Messner and Jelinek, 1970; Fr0land et al., 1974a) . Although Fc receptors are important for the phagocytosis of antigen-antibody complexes by monocytes and macrophages, Fudenberg, 1968, Huber, Douglas and Fudenberg, 1969) and in antibody-dependent lymphocyte-mediated cytotoxicity (Dickler, 1974; Wisl0ff, Fr0land and Michaelson, 1974 ) the functional significance of Fc receptors in vivo still remains unclear. Nevertheless, Fc receptors are to be found on many cell types, both phagocytic and non-phagocytic, involved in the immune response.
We have observed, as have Gutterman et al. (1973) that cells from patients with acute myeloid leukaemia (AML)* often have a characteristic staining pattern when reacted with fluorescein-conjugated antihuman Ig. This irregular and patchy staining is similar to that seen when aggregated IgG bound to lymphocyte Fc receptors is stained with an anti-immunoglobulin fluorescent conjugate (Dickler Fe RECEPTORS ON AML LEUCOCYTES and Kunkel, 1972; Dickler, 1974 that these receptors can be further unmasked or blocked respectively, suggesting that at least part of the AML surface Ig is bound in vivo to Fc receptors. The results in this paper also show that the relatively rapid rosette test described could be useful in the diagnosis of AMML using peripheral blood leucocytes, as an adjunct to conventional bone marrow diagnosis.
MATERIALS AND METHODS
Nlormal and AML leucocyte separations.-Venous blood from healthy adults and from untreated adult AML patients was anticoagulated with heparin (10 iu/ml) or by defibrination. Whole blood total white cell counts were performed on a Coulter Model " 5 " cell counter and differential cell counts were made using Romanowsky-stained blood smears. The blood was diluted 1: 1 with saline and layered on to a mixture of Ficoll (Pharmacia, Uppsala, Sweden) and Triosil (Nyegaard, Oslo, Norway) , centrifuged at 400 g for 40 min at 4°C (Boyum, 1968) Enzyme treatment of leucocytes.-Equal volumes (01 ml) of leucocytes (6 x 106/ml) and each of the following enzyme preparations in HBSS were incubated at 37°C for the following times: pronase (protease type VI, Sigma, London), 1 mg/ml-10 min; papain (Sigma, London), 1 mg/ml-10 min and trypsin (Wellcome Laboratories, Beckenham, Kent), 0-25 mg/ml-5 min. The enzymetreated leucocytes were then washed three times in HBSS, resuspended at a concentration of 3 x 106/ml and rosetted with HEA.
HEA-rosette inhibition.-Leucocytes (6 x 106/ml) from the interface of separated normal or AML blood were incubated for 30 min at 37°C with an equal volume (0.1 ml) of the following: normal AB or pretreatment AML serum centrifuged at 70,000 g for 5 h and separated into supernatant (deaggregated) and pellet fractions; human gamma-globulin (Cohn Fraction II, Sigma) or human albumin (Cohn Fraction V, Sigma), the latter two at concentrations of 1 mg/ml. The leucocytes were then washed by centrifugation three times in HBSS, resuspended at 3 x 106/ml and rosetted with HEA as previously described. Rosette formation by normal and AML leucocytes Using anti-D (Gm10) sensitized cDE/ cDE erythrocytes as indicator cells, receptors for human Ig were investigated on leucocytes from 11 normal individuals, 22 with untreated acute myeloid leukaemia, 2 with chronic lymphocytic leukaemia, 4 with chronic myeloid leukaemia, and one with adult lymphoblastic leukaemia. The results are depicted in Table II . The diagnoses, which in the case of the myeloid leukaemias were established by the examination of Romanowsky-stained bone marrow smears in the Department of Clinical Haematology, at the Manchester Royal Infirmary, were in most cases unknown to us at the time that peripheral blood leucocytes were assayed for HEA-RFC. The differential cell counts were performed in our own laboratory on the blood samples subsequently separated on Ficoll/Triosil, and in a number of cases differential counts were performed on the cells obtained after Ficoll/Triosil separation.
Blasts from the AML cell separations were found to accumulate mainly in the interface fraction, unless the peripheral leucocyte count was greater than 5 x 104/ mm3, in which case they were carried over into the sedimented fraction. In the majority of cases examined after Ficoll/ Triosil separation, there was an increase in the proportion of blasts in the interface fraction compared with the unseparated cells. In the 5 preparations of sedimented cells examined, nucleated cells other than blasts comprised the majority of cells.
Ficoll/Triosil separation is a method principally for separating lymphocytes from polymorphonuclear neutrophils (also referred to in this paper as " granulocytes ") and erythrocytes. To define the number of HEA-RFC in these two leucocyte fractions, results of 11 separations of normal leucocytes are shown. Nine Table VII ). (Table VII ). Strong inhibition was found by both fractions, the extent of the inhibition being greater with AML cells tha,n with normal leucocytes. Inhibition was also seen when normal and AML leucocytes were tested with Cohn fraction II gamma-globulin, though it was less in the normal than in AML leucocytes. Albumin (Cohn Fraction V) inhibited HEA-RFC in one AML leucocyte preparation, but was ineffective in the other two, and only slight inhibition was seen in 2 out of 3 normal leucocyte preparations.
DISCUSSION
This study shows that receptors for human immunoglobulin can be demonstrated on leucocytes from patients with untreated acute myeloid leukaemia by rosetting with homologous (anti-Rhesus) antibody-coated human Rh+ erythrocytes. Leucocytes from a variety of other leukaemias, including CML, CLL and ALL, and lymphoblastoid cell lines, did not rosette to any significant extent with HEA. In those cases where rosette formation occured with anti-D-coated erythrocytes, there was no evidence that unsensitized erythrocytes formed spontaneous rosettes with these leucocytes, which distinguishes the present results from those of a technique of rosette formation by activated human leucocytes with unsensitized human 0 Rh--erythrocytes (Sheldon and Holborrow, 1975) .
A critical factor in the detection of leucocytes bearing receptors for Ig, using the assay described here, is the source of the anti-Rh serum. We tested 7 different antisera in the HEA-RFC test with a panel of normal and AML leucocytes. The antibody giving the highest rosetting values with leucocytes from both sources was an incomplete anti-D (Gm10) typing serum, though similar values were obtained with anti-CDE and anti-D (Inv'). The anti-D (Gm'0) and the anti-CDE were the only sera of those tested, carrying the Gm'I allotype. It is thus significant that the Gm'0 allotype is restricted to the IgG3 sub-class (Martensson and Kunkel, 1965) whilst the Gm' and Gm2 allotypes are restricted to IgGl (Terry, Fahey and Steinberg, 1965 ; for review see Grubb, 1970) . Other workers have shown that whilst IgGI and IgG3 are efficient in-hibitors, both of the phagocytosis of antibody-coated erythrocytes by monocytes (Huber and Fudenberg, 1968) and HEA rosetting by lymphocytes, (Fr0land et al., 1974a) , IgGl is much less efficient than IgG3 in attaching to leucocyte Fc receptors (Abramson et al., 1970b) .
We observed quite marked differences in the capacity of AML leucocytes to form rosettes with different types of Rh+ erythrocyte sensitized with the same antiRh antibody. This was particularly the case when we compared homozygous D with heterozygous D erythrocytes, or D homozygous erythrocytes with or without the presence of C. Rochna and HughesJones (1965) have shown that cDE/cDE erythrocytes carry more anti-D combining sites (25,800-33,300) than CDe/cDE erythrocytes (23,000-31,000), the reason being that the C antigen on the CDe/cDE erythrocytes reduces the number of available D antigen combining sites. The concentration of D antigen combining sites, and hence the number of Ig molecules attached to the indicator erythrocyte, is important in identifying Fc receptors on leucocytes, according to Huber et al., (1969) who found that at least 5000 IgG molecules were needed per red cell to ensure attachment to a majority (> 900o) of monocytes.
In order to study the quantitative difference between acute myeloid leukaemic patients' leucocytes in the HEA-RFC test, we compared the results with normal leucocytes. Although the test could probably be done quite simply on dextranseparated leucocytes, we thought it important to establish the number of normal lymphocytes and granulocytes able to rosette with HEA. The mean HEA-RFC value for interface leucocytes (1 1.8%o) compares well with published values ( 150, Fr0land, Wisl0ff and Michaelson, 1974b) . We observed, as have Wisl0ff et al. (1974) , that most of the rosetted cells were lymphocytic in appearance, when we examined stained smears of rosetted interface normal leucocytes. The mean HEA-RFC value for the sedimented leucocytes 25 (2. 15 %) indicated that granulocytes do not easily rosette, using the assay described here. Messner and Jelinek (1970) , showed that granulocyte Fc receptors could be more easily identified using HE coated with the rare Ripley (anti-CD) serum, whereas normal anti-D-coated HE detected similar numbers of granulocyte HEA-RFC to those found here.
The spectrum of cells in the peripheral blood of acute myeloid leukaemic patients is far larger than in normal peripheral blood, and changes in the percentage of HEA-RFC in AML (Dickler and Kunkel, 1972) Abramson et al. (1970b) , who showed in addition that Fc fragments and y-1 and y-3 H-chains inhibited rosetting by leucocytes, whilst y-4 H-chain was less inhibitory, and Fab, F(ab')2 and albumin were almost non-inhibitory. Other authors (Messner and Jelinek, 1970, Fr0land et al., 1974a) have observed similar inhibition of HEA-RFC, but Dickler and Kunkel (1972) (Dickler and Sachs, 1974) .
This study has shown that cells identified morphologically as myeloblasts and monoblasts have Fc receptors, though we conclude that myeloblasts in patients with acute myeloblastic leukaemia may not be as efficient in rosetting as myeloblasts in AMML patients. The myeloblasts in acute myeloblastic and acute myelomonocytic leukaemia may thus differ in their expression or exposure of Fc receptors as identified in the HEA-RFC assay. Nevertheless, the good correlation of the results with the bone marrow diagnosis supports the contention that the HEA-RFC assay could be used to diagnose AMML cases using peripheral blood leucocytes.
